MedX Health Corp

MedX Health Corp

MDX · V · Healthcare / Medical Devices

0.04CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.04
Open0.04
Day Range0.04 – 0.04
52-Week Range0.04 – 0.07
Volume19.00K
Market Cap16.40M
P/E (TTM)0.00
Forward P/E13.50
EPS-0.02
Dividend Yield0.00%
Beta1.77
50-Day Avg0.0524
200-Day Avg0.057

About

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. John Gevisser
  • Employees0
  • Headquarters1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2, Canada
  • Websitehttps://www.medxhealth.com

Leadership

  • Mr. Stephen LockyerPresident & Director
  • Mr. Christopher H. FreemanCorporate Secretary & Acting CFO
  • Mr. Michael DruhanPresident of Dermatological Services & Products
  • Mr. John GevisserChief Executive Officer
  • Ms. Meghan GearyChief Operating Officer
  • Mr. Heinrich De LangeChief Technology Officer
  • Mr. Scott NaughtonManaging Director of US Operations

Financials

Income Statement

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue579.64K877.73K1.17M817.05K1.09M1.09M860.25K530.07K563.10K510.61K456.09K489.70K473.27K
Growth (%)-+51.43%+33.46%-30.25%+33.80%-0.53%-20.89%-38.38%+6.23%-9.32%-10.68%+7.37%-3.36%
Cost of Revenue269.80K390.71K509.79K379.23K478.75K398.24K380.43K261.96K289.76K270.66K270.46K295.47K325.70K
Gross Profit309.85K487.02K661.63K437.83K614.49K689.19K479.82K268.11K273.34K239.95K185.63K194.23K147.57K
Gross Margin53.45%55.49%56.48%53.59%56.21%63.38%55.78%50.58%48.54%46.99%40.70%39.66%31.18%
Operating Expense1.23M1.04M1.34M1.66M2.11M4.77M3.61M3.30M4.84M4.11M3.21M2.50M4.44M
Operating Income-922.88K-555.55K-681.61K-1.22M-1.49M-4.08M-3.13M-3.03M-4.56M-3.87M-3.03M-2.30M-4.29M
Operating Margin-159.22%-63.29%-58.19%-149.33%-136.67%-375.64%-363.90%-571.52%-810.29%-757.61%-663.99%-470.44%-906.90%
EBITDA-----1.39M-3.98M-3.02M-3.06M-4.49M-3.81M-2.38M-2.26M-4.48M
EBITDA Margin-----126.89%-366.36%-350.49%-577.64%-798.10%-746.82%-521.55%-460.88%-946.60%
Net Income-1.89M-204.58K-499.25K-1.34M-1.60M-4.19M-3.28M-3.20M-5.32M-5.13M-4.58M-3.65M-6.29M
Net Income Margin-326.47%-23.31%-42.62%-163.43%-146.76%-385.00%-380.86%-603.60%-945.40%-1005.41%-1004.31%-745.96%-1329.15%
R&D-182.46K182.46K182.46K182.46K880.77K535.46K431.16K995.36K681.79K586.08K526.28K500.00K
R&D as % of Total Revenue-20.79%15.58%22.33%16.69%81.00%62.25%81.34%176.76%133.53%128.50%107.47%105.65%
Interest Expense00000101.89K125.03K58.17K777.61K1.27M2.15M1.35M1.76M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%9.37%14.53%10.97%138.09%248.47%471.40%275.52%371.62%

Balance Sheet

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets600.20K475.94K654.05K798.07K670.98K652.16K435.90K734.39K731.06K718.23K689.61K884.15K702.33K
Total Liabilities4.00M2.74M3.05M2.62M2.17M2.20M3.30M2.80M4.36M7.80M7.83M9.41M10.44M
Total Equity-3.40M-2.26M-2.39M-1.83M-1.50M-1.54M-2.87M-2.07M-3.63M-7.08M-7.14M-8.52M-9.74M
Cash192.28K3.98K62.75K207.55K96.26K38.94K11.92K37.95K106.77K142.50K138.19K158.29K18.74K
Net Debt----626.89K495.06K740.08K878.33K2.47M4.72M5.65M6.82M7.91M

Cash Flow

Currency: CAD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-141.94K-864.08K-536.53K-1.33M-1.47M-2.61M-1.32M-2.91M-4.52M-2.80M-3.42M-2.51M-3.73M
Investing Cash Flow-13.49K-51.09K-281.71K-3.64K-1.17K-10.85K-4.44K-5.50K-----
Financing Cash Flow331.66K726.87K877.01K1.48M1.36M2.56M1.30M2.94M4.60M2.84M3.42M2.53M3.59M
Capital Expenditure13.49K51.09K4.70K3.64K1.17K10.85K4.44K5.50K16.49K0002.10K
Free Cash Flow-----1.47M-2.62M-1.33M-2.91M-4.53M-2.80M-3.42M-2.51M-3.73M
FCF to OCF----100.08%100.42%100.34%100.19%100.37%100.00%100.00%100.00%100.06%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017May 29, 2018Aug 23, 2018Nov 29, 2018Dec 31, 2018May 30, 2019Aug 28, 2019Nov 27, 2019Jun 12, 2020Sep 25, 2020Nov 27, 2020Apr 28, 2021Aug 24, 2021Nov 29, 2021May 1, 2022Aug 29, 2022Nov 29, 2022May 1, 2023Dec 1, 2026
EPS Estimate----------------------------------------------------------
EPS Actual-0.03-0.04-0.03-0.03-0.02-0.02-0.01-0.04-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.010.01-0.01-0.00-0.01-0.02-0.00-0.000.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.00-0.00-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.00-0.01-0.01-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.01-
Surprise----------------------------------------------------------
Timing----------------------------------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap16.40M
Enterprise Value25.07M
Trailing P/E0.00
Forward P/E13.50
PEG Ratio0.00
Price / Sales28.78
Price / Book0.00
EPS-0.02
Book Value-0.033
Revenue (TTM)569.79K
Gross Profit (TTM)-13.48K
EBITDA-4.29M
Profit Margin0.00%
Operating Margin-1027.89%
Return on Equity0.00%
Return on Assets-361.91%
Shares Outstanding327.93M
Shares Float214.49M
Beta1.77
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%